Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFennec Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.10 | -$0.07 | -$0.09 |
| Q2 2025 | 3 | -$0.04 | -$0.03 | -$0.03 |
| Q3 2025 | 2 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2025 | 1 | $0.03 | $0.04 | $0.03 |
| Q1 2026 | 2 | -$0.05 | $0.36 | $0.16 |
| Q2 2026 | 1 | $0.21 | $0.30 | $0.25 |
| Q3 2026 | 1 | $0.10 | $0.14 | $0.11 |
| Q4 2026 | 1 | $0.19 | $0.27 | $0.22 |
| Q1 2027 | 1 | $0.13 | $0.19 | $0.15 |
| Q2 2027 | 1 | $0.17 | $0.25 | $0.20 |
| Q3 2027 | 1 | $0.20 | $0.30 | $0.24 |
| Q4 2027 | 1 | $0.47 | $0.68 | $0.55 |
Fennec Pharmaceuticals Inc. Earnings Date And Information
Fennec Pharmaceuticals Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.06. The company had revenue of 12.46 M for the quarter and had revenue of 47.54 M for the year. Fennec Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($-0.016 diluted earnings per share) and currently has a price-to-earnings ratio of -30.34. Fennec Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based on prior year's report dates.
Fennec Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | -$0.08 | -$0.02 | 0.06 | $11.16 M | $12.46 M |
| 08/14/2025 | Q2 2025 | -$0.06 | -$0.12 | -0.06 | $9.63 M | $9.65 M |
| 05/14/2025 | Q1 2025 | N/A | -$0.04 | N/A | N/A | $8.75 M |
| 03/26/2025 | Q4 2024 | N/A | -$0.07 | N/A | N/A | $7.93 M |
| 11/08/2024 | Q3 2024 | N/A | -$0.21 | N/A | $9.09 M | $6.97 M |
| 08/13/2024 | Q2 2024 | $0.06 | -$0.20 | -0.26 | $11.08 M | $7.26 M |
| 05/14/2024 | Q1 2024 | $0.26 | $0.47 | 0.21 | N/A | $25.38 M |
| 03/29/2024 | Q4 2023 | N/A | -$0.10 | N/A | N/A | $10.00 M |
| 11/09/2023 | Q3 2023 | N/A | -$0.07 | N/A | $5.30 M | $6.52 M |
| 08/07/2023 | Q2 2023 | N/A | -$0.21 | N/A | $3.75 M | $3.37 M |
| 05/12/2023 | Q1 2023 | N/A | -$0.29 | N/A | $1.84 M | $1.68 M |
| 03/29/2023 | Q4 2022 | N/A | -$0.30 | N/A | $893.80 K | $1.54 M |
| 11/14/2022 | Q3 2022 | N/A | -$0.31 | N/A | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$0.10 | -$0.19 | -0.09 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.13 | -$0.15 | -0.02 | N/A | $0 |
| 02/28/2022 | Q4 2021 | $3.52 | -$0.17 | -3.69 | $50.00 M | $0 |
| 11/10/2021 | Q3 2021 | -$0.18 | -$0.16 | 0.02 | N/A | $0 |
| 08/10/2021 | Q2 2021 | -$0.19 | -$0.15 | 0.04 | N/A | $0 |
| 05/13/2021 | Q1 2021 | -$0.12 | -$0.18 | -0.06 | N/A | $0 |
| 03/30/2021 | Q4 2020 | -$0.19 | -$0.14 | 0.05 | N/A | $170.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fennec Pharmaceuticals Inc. Earnings: FAQ's
Fennec Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based offlast year's report dates.
In the previous quarter, Fennec Pharmaceuticals Inc. (:FENC) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.06.
The conference call for Fennec Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for Fennec Pharmaceuticals Inc.'s latest earnings report can be read online.
Fennec Pharmaceuticals Inc. (:FENC) has a recorded annual revenue of $47.54 M.
Fennec Pharmaceuticals Inc. (:FENC) has a recorded net income of $-436,000.Fennec Pharmaceuticals Inc. has generated $-0.016 earnings per share over the last four quarters.
Fennec Pharmaceuticals Inc. (:FENC) has a price-to-earnings ratio of -30.34 and price/earnings-to-growth ratio is -0.7.